Alzheimer’s Disease Blood Biomarkers
Overview
This presentation offers a clear introduction to emerging blood‑based biomarkers for Alzheimer’s disease. Alicia Algeciras‑Schimnich, Ph.D., explains how new blood tests can help detect the disease earlier and more easily by measuring indicators like amyloid, tau, and neurodegeneration markers. She highlights their potential impact on diagnosis, patient care, and future treatment development.
Presenter
Alicia Algeciras-Schimnich, Ph.D.
Professor of Laboratory Medicine and Pathology
Mayo Clinic, Rochester, Minnesota
Faculty disclosure
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
Questions
Contact us: mcleducation@mayo.edu
